The Bull Case for Zoetis Stock as Michael Burry Doubles Down Michael Burry, the hedge fund manager who famously shorted subprime mortgages, has increased his stake in Zoetis, a global animal health company.
This move is not without controversy, given concerns over safety and efficacy of some key products. However, what does Burry see that others don't? Is he right to bet big on this beleaguered industry leader?
Zoetis faces significant challenges. Its flagship dermatology franchise and Simparica Trio are struggling with increased competition from generic brands.